523 related articles for article (PubMed ID: 23577498)
1. Considerations in the choice and administration of agents for empiric antimicrobial therapy.
Baughman RP
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498
[TBL] [Abstract][Full Text] [Related]
2. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
3. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
[TBL] [Abstract][Full Text] [Related]
4. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
Ramsamy Y; Muckart DJ; Han KS
S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
[TBL] [Abstract][Full Text] [Related]
5. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
Boyd N; Nailor MD
Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
[TBL] [Abstract][Full Text] [Related]
6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
7. Emerging issues in the management of infections caused by multi-drug-resistant, gram-negative bacilli.
Rice LB
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-37-47. PubMed ID: 23577496
[TBL] [Abstract][Full Text] [Related]
8. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
9. New antibiotic agents: problems and prospects.
Weber DJ; Rutala WA
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
[TBL] [Abstract][Full Text] [Related]
10. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
11. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
Turina M; Cheadle WG
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
[TBL] [Abstract][Full Text] [Related]
12. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
13. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
Paterson DL
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S14-20. PubMed ID: 18713045
[TBL] [Abstract][Full Text] [Related]
14. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
15. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.
Maseda E; Denis SE; Riquelme A; Gilsanz F
Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465
[TBL] [Abstract][Full Text] [Related]
16. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.
Guervil DJ; Chau T
Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425
[TBL] [Abstract][Full Text] [Related]
17. Management of antibiotic resistance in the intensive care unit setting.
Petrosillo N; Capone A; Di Bella S; Taglietti F
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
[TBL] [Abstract][Full Text] [Related]
18. Current guidelines for the treatment of severe pneumonia and sepsis.
Bodmann KF
Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients).
Vasudevan A; Mukhopadhyay A; Goh EY; Li J; Tambyah PA
Prev Med; 2013; 57 Suppl():S70-3. PubMed ID: 23246839
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
